Adar Poonawalla Usa Britain covid-19 vaccine Coronavirus Adar Poonawalla Usa Britain

COVID-19 vaccine: Serum Institute ties-up with 5 candidates; Poonawalla says 'it will be affordable'

Reading now: 770
www.livemint.com

Mint.Under an agreement with US drug developer, Serum Institute will develop two billion doses of Novavax's vaccine candidate annually.

The drugmaker will also manufacture the antigen component of the vaccine. Novavax is currently conducting late-stage trials in Britain and expects to report resulby the first quarter of 2021."We have also partnered with US based Codagenix, which is in its pre-clinical trials phase and will move to the human trial phase by the end of 2020," Adar Poonawalla, chief executive officer, told Mint. "We have a global manufacturing and supply association with them," he further revealed."We are also researching on two candidates for the coronavirus vaccine," Poonawalla told Mint.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA